Rosen metodo centras - Company finances
|
EUR
|
2023
From: 2023-09-20
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | - | 6,162 | 6,140 |
| Profit before tax | -67 | 1,210 | -678 |
| Net profit | -67 | 1,153 | -678 |
| Equity | 435 | 1,588 | 911 |
| Liabilities | 0 | 157 | 190 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 435 | 1,745 | 1,101 |
| Total assets | 435 | 1,745 | 1,101 |
|
Taxes paid
|
|||
| STI taxes | - | - | 57 |
|
Financial indicators
|
|||
| Revenue change y/y | - | - | -0.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -15.4% | 66.1% | -61.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -15.4% | 72.6% | -74.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 18.7% | -11.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 19.6% | -11.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Rosen metodo centras - Social security debts
The company had no debts to Sodra
Rosen metodo centras - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Rosen metodo centras, MB (code 306436598) is a Small partnership engaged in Medical specialists activities. In 2025, the latest financial year, the company generated revenue of €6.1K, broadly unchanged from 2024, with year-on-year revenue growth of -0.4%. However, profitability weakened materially: net profit turned into a loss of €678, compared with a net profit of €1.2K in 2024, and the net margin stood at -11.0%. The company had already moved from a very small loss of €67 in the 102-day 2023 period to a profitable 2024, before returning to loss in 2025. On the balance sheet, total assets declined to €1.1K at the end of 2025 from €1.7K in 2024, while equity decreased to €911 and liabilities were €190. The debt-to-equity ratio was 0.21 and asset turnover reached 5.58x, indicating that the business generated revenue from a relatively small asset base. Return measures were negative in 2025, reflecting the loss for the year.